Business Description

10x Genomics Inc., founded in 2012 and headquartered in Pleasanton, California, United States, provides advanced genomic analysis systems that focus on single-cell and spatial genomics. The company’s primary revenue comes from its flagship Chromium system and recurring consumable sales, supporting cutting-edge research across academic and clinical settings. Led by CEO Serge Saxena since 2019, it holds a strong market position with significant technological advantages. Future growth is being driven by innovations in next-generation platforms and expanded market strategies.

Everything on 10x Genomics Inc.

Revenue (FY2025) $643M
YoY growth +5.2%
Operating margin -9.5%
Direction Expanding
Gross margin 69.1%
Net margin -6.8%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗

Share Repurchase Program

Item 5 (Issuer Purchases of Equity Securities) of the FY2025 10-K states "None"; the company has no share repurchase program.

Customer Concentration

For the years ended December 31, 2025, 2024, and 2023, no single customer represented more than 10% of revenue.

Recent SEC Filings

2026-06-08 Shareholder vote results View filing ↗
2026-05-07 Reported quarterly results View filing ↗
2026-02-12 Reported quarterly results View filing ↗
2026-01-12 Reported quarterly results View filing ↗
2025-11-14 Leadership change (directors/officers) View filing ↗
2025-11-06 Reported quarterly results View filing ↗
2025-08-07 Reported quarterly results View filing ↗
2025-06-05 Shareholder vote results View filing ↗
2025-05-14 Other event View filing ↗
2025-05-08 Reported quarterly results (+1 more) View filing ↗
2025-02-12 Reported quarterly results View filing ↗
2025-01-13 Reported quarterly results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.